Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2013 · 10-Q
Revenue$415.69K$415.69K+54.1% vs Q2 2012 Net Income-$32.34K-$32.34KN/M vs Q2 2012 EPS Diluted$0.00$0.00— vs Q2 2012 Gross Profit$185,998+144.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
derived
Margins · derivedGross margin44.7%+16.5 pt vs Q2 2012
Net margin-7.8%+3.2 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 12, 2013 · 43 d after period end